GTF2H2 Antibody

What is GTF2H2 and what cellular functions does it regulate?

GTF2H2 is a 44 kDa protein component of the general transcription and DNA repair factor IIH (TFIIH) core complex. It participates in two critical cellular processes:

• Transcription Initiation: When the pre-initiation complex (PIC) forms, TFIIH (including GTF2H2) facilitates promoter opening and promoter escape. The N-terminus of GTF2H2 interacts with and regulates XPD, while an intact C-terminus is essential for successful RNA polymerase II escape from the promoter .

• DNA Repair: GTF2H2 participates in general and transcription-coupled nucleotide excision repair (NER). During NER, TFIIH opens DNA around lesions, enabling excision of damaged oligonucleotides and their replacement with new DNA fragments .

GTF2H2 promotes TFIIH stability across multiple tissues and is indispensable for nucleotide excision repair by facilitating TFIIH recruitment to damaged DNA .

What are the common applications for GTF2H2 antibodies in molecular research?

GTF2H2 antibodies are versatile tools for multiple research applications:

When selecting application methods, researchers should consider that endogenous GTF2H2 expression may be extremely low in some cell types like HFFs, often below Western blot detection limits even with high antibody concentrations (1:250) .

How should researchers validate GTF2H2 antibodies before experimental use?

Proper validation is crucial for obtaining reliable results with GTF2H2 antibodies:

• Positive and negative controls: Use GTF2H2-overexpressing cells as positive controls. For negative controls, consider GTF2H2 knockdown cells using shRNA (targeting different sequences to exclude off-target effects) as demonstrated in studies examining GTF2H2's role in E2F1 activation .

• Cross-reactivity assessment: Confirm antibody specificity using Western blot. The predicted molecular weight for GTF2H2 is 44 kDa, with some isoforms at 49 kDa .

• Functional validation: If investigating GTF2H2's role in transcription regulation, verify antibody suitability for ChIP assays as demonstrated in studies where GTF2H2 binding to target promoters was analyzed in relation to E2F1 recruitment .

• Species reactivity confirmation: While many commercial GTF2H2 antibodies claim reactivity to human, mouse, and rat samples, validate this experimentally when working with non-human samples .

How does GTF2H2 interact with the transcription factor E2F1, and how can researchers study this interaction?

Recent research has identified GTF2H2 as an interacting factor with the N-terminal region of E2F1, with significant functional consequences:

• Interaction mechanism: The N-terminal region of E2F1 physically interacts with GTF2H2, as initially identified through yeast two-hybrid screening .

• Functional consequences: GTF2H2 overexpression enhances E2F1 induction of target genes (ARF, TAp73, ASPP1) and augments E2F1-mediated cell death. This enhancement depends on the integrity of E2F1's N-terminal region .

• Methodological approaches to study this interaction:

  • Co-immunoprecipitation: Though technically challenging due to low expression levels of both proteins in many cell types, using tagged proteins can improve detection .

  • Chromatin immunoprecipitation (ChIP): To analyze GTF2H2 recruitment to E2F1 target genes:

    • Fix cells with formaldehyde (typically 1%)

    • Sonicate chromatin to ~200-500 bp fragments

    • Immunoprecipitate with anti-E2F1 and anti-GTF2H2 antibodies

    • Analyze association with promoter regions of target genes via qPCR

  • Functional validation: Using both overexpression and knockdown approaches:

    • Measure activation of promoter-reporter constructs (e.g., ARF, TAp73)

    • Analyze expression of endogenous target genes via qRT-PCR

    • Assess phenotypic outcomes like cell death via FACS analysis of subG1 DNA content

What technical challenges exist when detecting endogenous GTF2H2, and how can they be overcome?

Detection of endogenous GTF2H2 presents several challenges:

• Low endogenous expression: GTF2H2 protein levels are extremely low in many cell types, including human fibroblasts (HFFs), where endogenous protein is undetectable by Western blot even with high antibody concentrations (1:250) .

Technical solutions:

• Protein concentration: Use immunoprecipitation to concentrate GTF2H2 before detection, potentially with GFP-tagged GTF2H2 to facilitate isolation.

• Sensitivity enhancement:

  • Use more sensitive detection methods like ECL Prime or SuperSignal West Femto

  • Consider longer exposure times and more sensitive imaging systems such as LAS4000 (GE Healthcare)

• Alternative detection methods:

  • qRT-PCR for mRNA expression when protein is undetectable

  • Consider knockin of tags (e.g., AID::GFP) at the C-terminus of the GTF2H2 gene using CRISPR/Cas9 for improved detection

• Quantification approaches:

  • When visible bands are obtained, use software such as ImageJ Version 1.51s (NIH) to measure signal intensity

  • Normalize to loading controls like β-actin

How can researchers effectively investigate GTF2H2's role in nucleotide excision repair (NER)?

To study GTF2H2's function in nucleotide excision repair:

• Generate appropriate model systems:

  • Create GTF2H2 knockout or knockdown cells using CRISPR/Cas9 or RNAi

  • Develop knockin animals with tagged GTF2H2 (e.g., AID::GFP) to track protein dynamics

• NER functional assays:

  • UV sensitivity assays: Compare survival rates of wild-type vs. GTF2H2-deficient cells after UV irradiation

  • DNA damage recruitment: Monitor recruitment of GTF2H2 and other TFIIH components to DNA damage sites using local UV irradiation and immunofluorescence

  • Repair kinetics assessment: Measure removal of UV-induced DNA lesions (CPDs, 6-4PPs) over time using specific antibodies

• Interaction studies:

  • Analyze how GTF2H2 affects the stability and composition of the TFIIH complex

  • Perform immunoprecipitation of TFIIH components (e.g., GTF2H1/p62) followed by mass spectrometry to assess complex integrity in the presence or absence of GTF2H2

Recent research demonstrated that C. elegans GTF-2H5 (TTDA ortholog) mutants showed impaired recruitment of TFIIH components like GTF-2H1 to UV-damaged DNA, highlighting the importance of properly functioning GTF2H components in the DNA repair process .

What strategies can researchers employ when Western blot detection of GTF2H2 yields weak or inconsistent results?

When encountering difficulties with GTF2H2 detection by Western blot:

• Antibody selection and optimization:

  • Test multiple antibodies targeting different epitopes of GTF2H2

  • Optimize antibody concentration; researchers have used concentrations as high as 1:250 for detection

  • Consider antibodies validated specifically for Western blot applications, such as those available from ThermoFisher (16005-1-AP, PA5-65462) or Boster Bio (A08466)

• Sample preparation improvements:

  • Use fresh lysates whenever possible

  • Include protease inhibitors to prevent degradation

  • Consider specialized lysis buffers optimized for nuclear proteins

  • Increase protein loading amounts (up to 50 μg per lane has been successful)

• Transfer and detection optimization:

  • Use PVDF membranes for better protein retention

  • Try longer transfer times for high molecular weight proteins

  • Employ enhanced chemiluminescence (ECL) detection systems

  • Use LAS4000 or similar sensitive imaging systems

• Positive control inclusion:

  • Include GTF2H2-overexpressing cell lysates as a positive control

  • Use human pancreas tissue lysate, which has been validated for GTF2H2 detection

• Alternative approaches:

  • If protein detection remains challenging, measure GTF2H2 at the mRNA level using qRT-PCR

  • Consider tagging endogenous GTF2H2 with GFP or other tags using CRISPR/Cas9 for easier detection

What controls should be included when studying GTF2H2's impact on gene expression and cell death?

When investigating GTF2H2's role in transcriptional regulation and apoptosis:

• Essential expression controls:

  • Protein level verification: Always confirm that GTF2H2 overexpression or knockdown does not affect expression levels of your protein of interest (e.g., E2F1) by Western blot analysis

  • Quantification: Use ImageJ or similar software to normalize protein signals to loading controls like β-actin

• Knockdown validation:

  • Use at least two different shRNAs targeting different sequences to exclude off-target effects

  • Confirm knockdown efficiency at mRNA level by qRT-PCR when protein is undetectable by Western blot

  • Include non-targeting shRNA as negative control

• Functional controls for gene expression studies:

  • Include both specific target genes (e.g., ARF, TAp73, ASPP1) and non-target genes

  • For reporter assays, include both wild-type and mutant constructs (e.g., testing E2F1 with and without its N-terminal region)

• Cell death assay controls:

  • Perform experiments in triplicate with appropriate statistical analysis

  • Include both positive controls (known inducers of cell death) and negative controls

  • Use multiple methods to assess cell death beyond subG1 DNA content, such as Annexin V/PI staining or caspase activation assays

• Specificity controls:

  • For ChIP experiments, include control regions (non-target genes)

  • For differential gene regulation, compare physiological E2F1 activity (serum stimulation) versus deregulated E2F1 activity (overexpression or adenovirus E1a expression)

How can ChIP experiments be optimized to study GTF2H2 recruitment to specific genomic loci?

To optimize chromatin immunoprecipitation (ChIP) for GTF2H2:

• Antibody selection and validation:

  • Test antibodies specifically validated for ChIP applications

  • Perform preliminary ChIP-qPCR on known target regions before proceeding to genome-wide studies

• Experimental design considerations:

  • Cell number optimization: Start with 2-5×10^6 cells per IP reaction

  • Crosslinking conditions: Use 1% formaldehyde for 10 minutes at room temperature

  • Sonication parameters: Optimize sonication to generate chromatin fragments of 200-500 bp

  • Beads selection: Protein A/G beads work well for most antibodies

• Controls to include:

  • Input control: Save 5-10% of chromatin before immunoprecipitation

  • IgG control: Use species-matched IgG as negative control

  • Positive control: Include antibodies against well-characterized proteins (e.g., RNA Pol II)

  • Biological comparisons:

    • Serum-starved vs. serum-stimulated cells to compare physiological E2F1 activity

    • Control vs. E2F1-overexpressing cells

    • Wild-type E2F1 vs. ΔNE2F1 (N-terminal deletion) to assess GTF2H2 recruitment specificity

• qPCR primer design:

  • Target regions: Design primers for promoter regions of known target genes (e.g., MCM6, ARF, TAp73)

  • Control regions: Include non-E2F1 target regions as negative controls

  • Primer characteristics: Design 18-27bp primers with similar Tm values, generating 80-150bp amplicons

• Data analysis and normalization:

  • Calculate percent input or fold enrichment over IgG control

  • Compare GTF2H2 binding patterns between different experimental conditions

  • Correlate GTF2H2 binding with E2F1 binding at the same loci

How do researchers interpret differential GTF2H2 recruitment patterns in relation to transcriptional outcomes?

Interpreting GTF2H2 recruitment in a transcriptional context requires multilayered analysis:

• Correlation with transcription factor binding:

  • In E2F1 studies, GTF2H2 recruitment patterns closely follow E2F1 binding profiles

  • Different target genes show selective recruitment patterns:

    • Both physiological E2F1 (serum-stimulated) and deregulated E2F1 recruit GTF2H2 to growth-related genes like MCM6

    • Only deregulated E2F1 (overexpression or viral E1a) recruits GTF2H2 to tumor suppressor genes like ARF and TAp73

• Temporal dynamics analysis:

  • Monitor GTF2H2 recruitment over time after stimulation

  • Correlate recruitment timing with transcriptional activation phases

  • For DNA repair studies, analyze timing of GTF2H2 recruitment to damaged DNA (e.g., 10 min post-UV damage vs. 35 min post-UV)

• Domain-specific interactions:

  • The N-terminal region of E2F1 is required for GTF2H2 recruitment

  • ΔNE2F1 (lacking N-terminal 89 amino acids) shows reduced ability to recruit GTF2H2 to target promoters

  • This coincides with reduced transcriptional activation of target genes

• Quantitative correlation with gene expression:

  • Create datasets correlating:

    • GTF2H2 binding strength (ChIP signal)

    • Target gene expression levels (qRT-PCR)

    • Transcription factor binding (e.g., E2F1)

  • Look for threshold effects or linear relationships between recruitment and expression

• Interpretation frameworks:

  • GTF2H2 functions as a coactivator enhancing transcription factor activity

  • Its recruitment likely stabilizes transcription factor binding to target genes

  • The degree of enhancement may be gene-context dependent

What methods can effectively discriminate between GTF2H2's roles in transcription versus DNA repair?

Distinguishing GTF2H2's dual functions requires targeted experimental approaches:

• Temporal separation of functions:

  • Transcription: Analyze GTF2H2 function in unstressed cells during normal transcription

  • DNA repair: Examine GTF2H2 recruitment specifically after DNA damage induction

  • Compare recruitment kinetics between these contexts

• Spatial localization analysis:

  • Use immunofluorescence to track GTF2H2 relocalization after DNA damage

  • Employ proximity ligation assays to detect GTF2H2 interactions with:

    • Transcription factors (E2F1) for transcription function

    • DNA damage recognition proteins (XPA) for repair function

• Domain-specific mutants:

  • The N-terminus of GTF2H2 interacts with and regulates XPD

  • The C-terminus is required for RNAP II promoter escape

  • Create domain-specific mutants to selectively impair each function

• Functional readouts:

  • Transcription: Measure promoter activation, gene expression, cell proliferation

  • DNA repair: Assess UV sensitivity, unscheduled DNA synthesis, CPD removal kinetics

  • In C. elegans, GTF-2H5 mutants show strong UV hypersensitivity despite viable transcription

• Context-dependent recruitment analysis:

  • Compare GTF2H2 binding patterns genome-wide in:

    • Normal transcriptional activation (e.g., serum stimulation)

    • DNA damage response (UV or chemical damage)

  • Identify differential binding partners in each context

What are the considerations when using GTF2H2 antibodies for mass spectrometry-based proteomics studies?

For successful GTF2H2-focused proteomics experiments:

• Antibody selection criteria:

  • Choose high-specificity antibodies with minimal cross-reactivity

  • Select antibodies that efficiently immunoprecipitate GTF2H2 and associated complexes

  • Consider using multiple antibodies targeting different epitopes to validate findings

• Sample preparation optimizations:

  • Cell types: Select cells with sufficient GTF2H2 expression or consider overexpression systems

  • Crosslinking options:

    • No crosslinking for direct interactors

    • Mild formaldehyde crosslinking (0.1-0.5%) for capturing transient interactions

  • Lysis conditions: Use buffers that preserve protein complexes while efficiently extracting nuclear proteins

• Immunoprecipitation strategies:

  • For challenging targets like GTF2H2 with low expression, consider:

    • Epitope-tagged versions (GFP, FLAG) for more efficient pulldown

    • Tandem purification methods to reduce background

    • Scaling up cell numbers to improve signal

• Control samples:

  • Input control: Total lysate before IP

  • IgG control: Non-specific antibody of same isotype

  • Biological variations:

    • Wild-type vs. GTF2H2 knockdown/knockout

    • Different cellular contexts (normal vs. DNA damage)

• Analysis considerations:

  • Focus on proteins consistently enriched across replicates

  • Compare against CRAPome or similar databases to filter common contaminants

  • Validate key interactions through orthogonal methods (e.g., co-IP, proximity ligation)

  • Previous studies identified the entire TFIIH complex co-immunoprecipitating with AG::GTF-2H1, including GTF-2H5 represented by three peptides

How can researchers effectively measure and interpret changes in TFIIH complex integrity when GTF2H2 is altered?

To assess how GTF2H2 modifications affect TFIIH complex stability:

• Quantitative complex integrity assessment:

  • Immunoprecipitate a TFIIH component (e.g., GTF2H1/p62) followed by Western blot or mass spectrometry

  • Compare stoichiometry of TFIIH subunits between conditions

  • In GTF-2H5 mutant C. elegans, mass spectrometry showed the TFIIH complex remained intact but at reduced abundance

• Expression level analysis:

  • Measure levels of multiple TFIIH subunits when GTF2H2 is modified

  • In studies, loss of GTF-2H5 led to reduced levels of other TFIIH components by more than 50% across tissues

• Functional assessments:

  • Transcription assays: Measure TFIIH-dependent transcription activity

  • Repair capacity: Assess NER efficiency through UV sensitivity assays

  • Complex recruitment: Analyze ability of TFIIH to be recruited to:

    • Promoters during transcription

    • DNA damage sites during repair

• Visualization approaches:

  • Use fluorescently tagged TFIIH subunits to monitor complex dynamics

  • Assess co-localization of multiple subunits under different conditions

  • Analyze recovery kinetics after photobleaching to measure complex stability

• Interpretation framework:

  • GTF2H2 likely functions as a stabilizing component of TFIIH

  • Its absence does not prevent complex formation but reduces steady-state levels

  • This has variable impact depending on cellular demand for TFIIH function

  • In C. elegans, GTF-2H5 absence is compatible with life under normal conditions but causes mortality when transcription is challenged

How can GTF2H2 antibodies be employed to investigate the interface between transcription regulation and cancer biology?

GTF2H2 research offers insights into cancer mechanisms through several experimental approaches:

• E2F1-dependent tumor suppressor activation:

  • GTF2H2 enhances E2F1 activation of tumor suppressor genes (ARF, TAp73, ASPP1)

  • Experimental approaches:

    • Measure tumor suppressor expression after GTF2H2 overexpression/knockdown

    • Correlate GTF2H2 levels with tumor suppressor activation in cancer cell lines

    • Analyze effects on cell cycle arrest and apoptosis in cancer contexts

• Cell death regulation studies:

  • GTF2H2 overexpression enhances E2F1-mediated cell death

  • GTF2H2 knockdown reduces E2F1-induced cell death

  • Experimental design:

    • Measure percentage of cells with subG1 DNA content by FACS analysis

    • Use multiple cell death markers (Annexin V, caspase activation)

    • Compare effects in normal versus transformed cells

• DNA repair capacity assessment:

  • GTF2H2's role in NER affects genomic stability

  • Approaches:

    • Compare UV sensitivity between control and GTF2H2-depleted cells

    • Assess accumulation of DNA damage in GTF2H2-deficient cells

    • Correlate repair capacity with cancer risk or treatment response

• Transcriptional program analysis:

  • Perform RNA-seq after GTF2H2 modulation to identify regulated gene networks

  • Compare transcriptional changes between normal and cancer cells

  • Identify cancer-specific vulnerabilities related to GTF2H2 function

What are the current technical limitations in studying GTF2H2 and how might they be overcome in future research?

Current challenges and potential solutions in GTF2H2 research:

• Low endogenous expression:

  • Current limitation: GTF2H2 protein levels are often below detection threshold

  • Emerging solutions:

    • More sensitive detection methods (super-resolution microscopy)

    • Endogenous tagging using CRISPR/Cas9 knock-in approaches

    • Single-molecule tracking technologies to visualize individual molecules

• Distinguishing dual functions:

  • Current limitation: Difficult to separate GTF2H2's roles in transcription vs. DNA repair

  • Emerging solutions:

    • Domain-specific mutants affecting one function but not the other

    • Acute protein degradation systems (e.g., auxin-inducible degron technology)

    • Structural studies to design function-specific inhibitors

• Complex regulatory networks:

  • Current limitation: GTF2H2 functions within large macromolecular complexes

  • Emerging solutions:

    • Cryo-EM structures of TFIIH in different functional states

    • Proximity-dependent labeling methods (BioID, APEX)

    • Single-cell approaches to capture heterogeneity in GTF2H2 function

• Tissue-specific functions:

  • Current limitation: Difficulty studying GTF2H2 in specialized cell types

  • Emerging solutions:

    • Conditional knockout models for tissue-specific depletion

    • Organoid systems to model tissue-specific roles

    • In vivo imaging of tagged GTF2H2 in complex tissues

• Translational relevance:

  • Current limitation: Unclear connection to human disease beyond rare syndromes

  • Emerging solutions:

    • Patient-derived cells with naturally occurring GTF2H2 variations

    • CRISPR screens to identify synthetic lethal interactions with GTF2H2

    • Pharmacological approaches to modulate GTF2H2 function in disease contexts